HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Inhaled therapy reduces morning dips in asthma.

Abstract
14 asthmatic patients with nocturnal symptoms and morning dips in peak expiratory flow rate (PEFR) were treated with regular inhaled salbutamol for 1 or 2 weeks, followed by regular inhaled beclomethasone dipropionate, in addition to salbutamol, for a further 2 weeks. Mean PEFR rose to normal values in all but 1 patient. Morning dips in PEFR were substantially reduced in 8 patients. There was an equivalent rise in mean PEFR in the other 6 patients, but their morning dips did not improve. Inhaled salbutamol reduced the dips in the responsive patients, but addition of inhaled steroid produced further improvement. Inhaled beta agonist alone improved mean PEFR in these patients, but inhaled steroids produced most of the improvement in the other subgroup. No patient experienced side-effects. Thus mean PEFR can be improved and morning dips in PEFR reduced in a high proportion of asthmatic patients by the use of regular inhaled therapy without resorting to less-well-tolerated oral agents.
AuthorsC R Horn, T J Clark, G M Cochrane
JournalLancet (London, England) (Lancet) Vol. 1 Issue 8387 Pg. 1143-5 (May 26 1984) ISSN: 0140-6736 [Print] England
PMID6144875 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Aerosols
  • Beclomethasone
  • Albuterol
Topics
  • Adolescent
  • Adult
  • Aerosols
  • Albuterol (administration & dosage)
  • Asthma (drug therapy, physiopathology)
  • Beclomethasone (administration & dosage)
  • Child
  • Circadian Rhythm
  • Drug Therapy, Combination
  • Female
  • Humans
  • Male
  • Middle Aged
  • Peak Expiratory Flow Rate
  • Random Allocation

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: